Objectives: Human Leukocyte Antigen HLA-B*57:01 and B*58:01 are considered anti-HIV-1 protective alleles. HLA-B*57:01/58:01-restricted HIV-1 Gag TW10 (TSTLQEQIGW, Gag residues 240-249) epitope-specific CD8+ T cell responses that frequently select for a Gag escape mutation, T242N, with viral fitness cost are crucial for HIV-1 control. Although this finding has been observed in cohorts where HIV-1 subtype B or C predominates, the protective impact of HLA-B*57:01/58:01 has not been reported in Southeast Asian countries where HIV-1 CRF01_AE is the major circulating strain. Here, the effect of HLA-B*57:01/58:01 on CRF01_AE infection was investigated. Methods: The correlation of HLA-B*57:01/58:01 with viral load and CD4 counts were analyzed in th...
Objective: HLA-B*27 and B*57 are associated with relatively slow progression to AIDS. Mechanisms hel...
Objective: HLA-B*27 and B*57 are associated with relatively slow progression to AIDS. Mechanisms hel...
Molecular epidemiology studies have identified HLA-B*58:01 as a protective HIV allele. However, not ...
Introduction: The design of a globally effective vaccine rests on the identification of epitopes cap...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
BACKGROUND: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversi...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
Background: HLA-B*35 is an HLA allele associated with rapid progression to AIDS. However, a mechanis...
BACKGROUND: The human leukocyte antigen (HLA)-restricted cytotoxic T-lymphocyte (CTL) immune respons...
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversi...
<div><h3>Introduction</h3><p>The design of a globally effective vaccine rests on the identification ...
Despite the introduction of antiretroviral therapy, the HIV/HIV epidemic remains an unsolved global...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Objective: HLA-B*27 and B*57 are associated with relatively slow progression to AIDS. Mechanisms hel...
Objective: HLA-B*27 and B*57 are associated with relatively slow progression to AIDS. Mechanisms hel...
Molecular epidemiology studies have identified HLA-B*58:01 as a protective HIV allele. However, not ...
Introduction: The design of a globally effective vaccine rests on the identification of epitopes cap...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
BACKGROUND: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversi...
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequ...
Background: HLA-B*35 is an HLA allele associated with rapid progression to AIDS. However, a mechanis...
BACKGROUND: The human leukocyte antigen (HLA)-restricted cytotoxic T-lymphocyte (CTL) immune respons...
CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversi...
<div><h3>Introduction</h3><p>The design of a globally effective vaccine rests on the identification ...
Despite the introduction of antiretroviral therapy, the HIV/HIV epidemic remains an unsolved global...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The u...
Objective: HLA-B*27 and B*57 are associated with relatively slow progression to AIDS. Mechanisms hel...
Objective: HLA-B*27 and B*57 are associated with relatively slow progression to AIDS. Mechanisms hel...
Molecular epidemiology studies have identified HLA-B*58:01 as a protective HIV allele. However, not ...